Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-22
2005-02-22
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S013800, C514S183000, C514S227800, C514S255030, C514S285000, C514S561000, C536S017400, C536S018700, C558S286000, C540S476000, C540S479000, C540S482000, C544S284000, C544S353000, C546S097000
Reexamination Certificate
active
06858624
ABSTRACT:
This invention is directed to compounds of the formula (I):and their pharmaceutically acceptable salts, wherein R1, R2, and R3are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of nicotine addiction/withdrawal and CNS disorders.
REFERENCES:
patent: 5663377 (1997-09-01), Curley et al.
patent: 5977131 (1999-11-01), Nagel
patent: 6020335 (2000-02-01), Nagel et al.
patent: 6605610 (2003-08-01), Coe et al.
patent: 0955301 (1999-03-01), None
patent: WO 9818798 (1998-05-01), None
patent: WO 9935131 (1999-07-01), None
patent: WO 9955680 (1999-11-01), None
patent: WO 0162736 (2001-08-01), None
Hagen Anne E.
Obach R. Scott
Khare Devesh
Pfizer Inc.
Pfizer Products Inc.
Scully Scott Murphy & Presser
Wilson James O.
LandOfFree
Aryl fused azapolycyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl fused azapolycyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl fused azapolycyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3497056